Web14 Apr 2024 · In the IMPROVE-IT trial, researchers showed adding ezetimibe to moderate-intensity statins vs. moderate intensity statin alone in ASCVD patients resulted in lower LDL cholesterol levels and reduced ASCVD events, especially in those older than age 75 years. 1 However, most guidelines recommend high-intensity statin therapy for secondary … Web26 Mar 2024 · Statins may prevent recurrent ischemic events after ischemic stroke. Determining which statin to use remains controversial. We aimed to summarize the …
Secondary Prevention of MACEs Necessary Following Lobar ICH
WebAfter 5 years of daily statin therapy study subjects achieved a 1.2% lower chance of death, a 2.6% lower chance of heart attack, and a 0.8% lower chance of stroke. As a public health … WebContext. Stroke is one of the major causes of worldwide death and disability, with one in four people predicted to experience a stroke within their lifetime. 1 After a stroke or a TIA, … cheap smartwatches
Contemporary Antiplatelet and Anticoagulant Therapies for Secondary …
WebThe guideline recommends the use of a high intensity statin (greater than 40% LDL-c lowering) of low acquisition cost in primary and secondary prevention of cardiovascular … Web14 Apr 2024 · In the IMPROVE-IT trial, researchers showed adding ezetimibe to moderate-intensity statins vs. moderate intensity statin alone in ASCVD patients resulted in lower … Webfor secondary prevention. The management of risk factors is a crucial issue for the prevention of further strokes. In addition, a number of drugs have been shown to be quite useful and can prevent a second occurrence after a transient ischemic attack or stroke. Among them are antithrombotics, statins and a number of cheap smart watch ebay uk